We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRSU
726
Pursuit Attractions and Hospitality Inc
PRSU
$1.48B
$290K 0.03%
+8,089
New +$275K
RDDT icon
727
Reddit
RDDT
$34.4B
$288K 0.03%
+4,374
New +$270K
BRX icon
728
Brixmor Property Group
BRX
$9.77B
$288K 0.03%
+10,335
New +$267K
SCCO icon
729
Southern Copper
SCCO
$140B
$287K 0.03%
+2,638
New +$260K
SVC
730
Service Properties Trust
SVC
$1.09B
$287K 0.03%
+12,592
New +$313K
HNRG icon
731
Hallador Energy
HNRG
$689M
$285K 0.03%
30,270
+1,055
+4% +$7.5K
IDA icon
732
Idacorp
IDA
$8.24B
$285K 0.03%
+2,760
New +$276K
NVRO
733
DELISTED
NEVRO CORP.
NVRO
$283K 0.03%
50,600
-16,820
-25% -$118K
HHH icon
734
Howard Hughes
HHH
$4B
$283K 0.03%
3,652
-6,586
-64% -$465K
GDOT icon
735
Green Dot
GDOT
$758M
$282K 0.03%
24,069
-38,837
-62% -$406K
MAA icon
736
Mid-America Apartment Communities
MAA
$15.8B
$281K 0.03%
+1,767
New +$269K
LPLA icon
737
LPL Financial
LPLA
$27.4B
$281K 0.03%
1,206
-2,678
-69% -$603K
AUR icon
738
Aurora
AUR
$12.2B
$280K 0.03%
+47,379
New +$197K
TGI
739
DELISTED
Triumph Group
TGI
$280K 0.03%
21,748
-2,069
-9% -$30K
RLAY icon
740
Relay Therapeutics
RLAY
$3.99B
$280K 0.03%
+39,584
New +$296K
NPK icon
741
National Presto Industries
NPK
$884M
$280K 0.03%
+3,726
New +$278K
ACVA icon
742
ACV Auctions
ACVA
$1.43B
$277K 0.03%
+13,646
New +$252K
AGYS icon
743
Agilysys
AGYS
$3.12B
$277K 0.03%
2,542
-3,689
-59% -$395K
CAL icon
744
Caleres
CAL
$447M
$276K 0.03%
+8,354
New +$303K
DLX icon
745
Deluxe
DLX
$1.25B
$275K 0.03%
14,127
-13,302
-48% -$278K
IRDM icon
746
Iridium Communications
IRDM
$4.81B
$274K 0.03%
+9,006
New +$245K
RITM icon
747
Rithm Capital
RITM
$5.46B
$274K 0.03%
+24,137
New +$275K
IAG icon
748
IAMGOLD
IAG
$8.24B
$271K 0.03%
+51,821
New +$239K
MBUU icon
749
Malibu Boats
MBUU
$559M
$271K 0.03%
+6,981
New +$251K
TU icon
750
Telus
TU
$16.7B
$271K 0.03%
16,145
-21,556
-57% -$348K
28 29
30
31 32

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.